CapitaLand is transforming the face of 1 Science Park Drive with an impressive redevelopment project that includes three interconnected Grade A buildings, aiming to revitalize the Singapore Science Park into a vibrant hub for innovation. With an investment of S$883 million, this ambitious initiative covers a total gross floor area of approximately 116,200 square meters and has been strategically positioned at the main entrance of Singapore Science Park (SSP).
By March 2025, the project had already achieved a remarkable 95% leasing milestone, emphasizing its appeal to tenants in life sciences, innovation, and technology sectors. Out of the 103,200 square meters of net lettable area, 76% has been leased, while negotiations are underway for an additional 19%. The temporary occupation permit obtained on 3 March 2025 ensures that the site will be ready for tenants soon. The buildings offer wet-lab ready spaces and business-ready facilities, catering to the specific needs of modern R&D companies. The total project area also contributes significantly to the Geneo life sciences cluster, which comprises five operational buildings at Singapore Science Park.
By March 2025, the redevelopment achieved a remarkable 95% leasing milestone, highlighting its appeal to life sciences and tech tenants.
The design of these interconnected buildings is exquisite, complemented by an event plaza and enhanced amenities, including retail spaces and food and beverage options. Connectivity is seamless, with an underground walkway that links directly to Kent Ridge MRT station, making access to the site remarkably convenient for tenants and visitors alike.
Adding a unique touch, CapitaLand has partnered with NSG BioLabs to introduce its first coworking laboratory space within the development.
The project’s commitment to sustainability is equally significant. It has received the Building and Construction Authority’s Green Mark Platinum rating and gained WELL Core Gold pre-certification, reflecting a focus on energy efficiency, healthier living standards, and eco-friendly features.
Jointly owned by CapitaLand Development and CapitaLand Ascendas REIT, this redevelopment is part of a broader initiative aimed at positioning SSP as a leading hub for biomedical research and innovation in Asia.
